Related Experiment Video

Updated: Jun 10, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

Michael S Bronze1, James B Dale

  • 1Division of Infectious Diseases, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190, USA. Michael-Bronze@ouhsc.edu

The American Journal of the Medical Sciences
|August 11, 2010
PubMed

Insights

Developing vaccines against virulent Gram-positive bacteria like Staphylococcus aureus, group B streptococci, and group A streptococci is crucial for preventing serious infections and improving patient outcomes. This review explores current vaccine development strategies for these significant pathogens.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Virulent Gram-positive bacterial infections, including Staphylococcus aureus, group B streptococci, and group A streptococci, are major contributors to illness and death.
  • Despite advances in antimicrobial treatments and understanding pathogenesis, effective infection prevention strategies remain limited.

Purpose of the Study:

  • This review aims to summarize the ongoing research and development of safe and effective vaccines against three key Gram-positive pathogens.
  • To highlight the progress and challenges in creating preventative measures for these widespread infections.

Main Methods:

  • Literature review of published studies on vaccine development for Staphylococcus aureus, group B streptococci, and group A streptococci.
  • Analysis of current vaccine candidates, including their platforms, targets, and preclinical/clinical trial outcomes.

Main Results:

  • Several vaccine candidates targeting different virulence factors and surface antigens are in various stages of development.
  • Challenges include achieving broad protection, ensuring safety, and overcoming immune evasion mechanisms of these bacteria.

Conclusions:

  • Vaccine development offers a promising avenue for preventing infections caused by Staphylococcus aureus, group B streptococci, and group A streptococci.
  • Continued research and innovation are essential to bring effective vaccines to clinical use and reduce the burden of these infections.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...